MARC 主機 00000nam a2200421 i 4500 
001    978-3-319-06752-0 
003    DE-He213 
005    20141226160029.0 
006    m     o  d         
007    cr nn 008maaau 
008    140916s2014    gw      s         0 eng d 
020    9783319067520 (electronic bk.) 
020    9783319067513 (paper) 
040    GP|cGP|erda 
041 0  eng 
082 04 616.994061|223 
245 00 Resistance to proteasome inhibitors in cancer :|bmolecular
       mechanisms and strategies to overcome resistance /|cedited
       by Q. Ping Dou 
264  1 Cham :|bSpringer International Publishing :|bImprint: 
       Springer,|c2014 
300    1 online resource (xi, 390 pages) :|billustrations, 
       digital ;|c24 cm 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
347    text file|bPDF|2rda 
490 1  Resistance to targeted anti-cancer therapeutics,|x2196-
       5501 
650  0 Protease inhibitors|xTherapeutic use 
650  0 Cancer|xChemotherapy 
650 14 Biomedicine 
650 24 Cancer Research 
650 24 Drug Resistance 
650 24 Pharmacology/Toxicology 
650 24 Molecular Medicine 
700 1  Dou, Q. Ping,|eeditor 
710 2  SpringerLink (Online service) 
773 0  |tSpringer eBooks 
830  0 Resistance to targeted anti-cancer therapeutics 
856 40 |uhttp://dx.doi.org/10.1007/978-3-319-06752-0